COVID-19 anti-viral therapy / Northeastern University, Audax Medical - LARVOL DELTA

Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics. (PubMed, Nanomedicine (Lond)) - "In this review, for the first time, we touch on some promising alternative approaches to treat viral infections, specifically those focused on the use of platform nanomaterials with antiviral peptides. In doing so, this review presents a timely discussion of how we need to change our old way of treating viruses into one that can quickly meet the demands of COVID-19, as well as future pandemic-causing viruses, which will come."

Journal • Infectious Disease • Novel Coronavirus Disease